Huszár, Zsolt
Solomon, Alina
Engh, Marie Anne
Koszovácz, Vanda
Terebessy, Tamás
Molnár, Zsolt
Hegyi, Péter
Horváth, András
Mangialasche, Francesca
Kivipelto, Miia
Csukly, Gábor
Funding for this research was provided by:
Hungarian Scientific Research Fund (138385, 138385, 138385, 138385, 138385, 138385, 138385, 138385)
EU Joint Programme – Neurodegenerative Disease Research (2019-2.1.7-ERA-NET-2020-00006, 2019-2.1.7-ERA-NET-2020-00006, 2019-2.1.7-ERA-NET-2020-00006)
European Research Council (804371, 804371, 804371)
Article History
Received: 26 June 2024
Accepted: 14 October 2024
First Online: 26 October 2024
Declarations
:
: ADNI investigators obtained ethics approval from the local ethical committees of all involved sites. Access to all ADNI data was granted to us after registration to ADNI () and compliance with the data usage agreement. All work complied with ethical regulations for work with human participants. In accordance with the Declaration of Helsinki (consent for research), written informed consent was obtained from each participant or their designated representative. Ethics approval was obtained from the institutional review boards of each institution involved: Oregon Health and Science University; University of Southern California; University of California—San Diego; University of Michigan; Mayo Clinic, Rochester; Baylor College of Medicine; Columbia University Medical Center; Washington University, St. Louis; University of Alabama at Birmingham; Mount Sinai School of Medicine; Rush University Medical Center; Wien Center; Johns Hopkins University; New York University; Duke University Medical Center; University of Pennsylvania; University of Kentucky; University of Pittsburgh; University of Rochester Medical Center; University of California, Irvine; University of Texas Southwestern Medical School; Emory University; University of Kansas, Medical Center; University of California, Los Angeles; Mayo Clinic, Jacksonville; Indiana University; Yale University School of Medicine; McGill University, Montreal-Jewish General Hospital; Sunnybrook Health Sciences, Ontario; U.B.C. Clinic for AD & Related Disorders; Cognitive Neurology—St. Joseph’s, Ontario; Cleveland Clinic Lou Ruvo Center for Brain Health; Northwestern University; Premiere Research Inst (Palm Beach Neurology); Georgetown University Medical Center; Brigham and Women’s Hospital; Stanford University; Banner Sun Health Research Institute; Boston University; Howard University; Case Western Reserve University; University of California, Davis—Sacramento; Neurological Care of CNY; Parkwood Hospital; University of Wisconsin; University of California, Irvine—BIC; Banner Alzheimer’s Institute; Dent Neurologic Institute; Ohio State University; Albany Medical College; Hartford Hospital, Olin Neuropsychiatry Research Center; Dartmouth-Hitchcock Medical Center; Wake Forest University Health Sciences; Rhode Island Hospital; Butler Hospital; UC San Francisco; Medical University South Carolina; St. Joseph’s Health Care Nathan Kline Institute; University of Iowa College of Medicine; Cornell University and University of South Florida: USF Health Byrd Alzheimer’s Institute ().
: Not applicable.
: The authors declare no competing interests.